Regulation FD Disclosure

Business Context and Reporting Period

This Form 8-K is a Current Report filed by Galecto, Inc. (not Damora Therapeutics, Inc.) on January 12, 2026. The registrant is a Delaware corporation with its principal executive offices in Boston, MA, and its common stock trades on The Nasdaq Capital Market under the symbol GLTO.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of upcoming investor communications rather than a financial results announcement.

Material Changes

No material financial changes or operational updates are detailed in the text of this filing. The document solely announces the Company's intent to participate in the 44th Annual J.P. Morgan Healthcare Conference.

Guidance, Outlook, and Management Commentary

  • Investor Relations Activity: Galecto, Inc. intends to conduct meetings with securities analysts and investors starting January 12, 2026, at the 44th Annual J.P. Morgan Healthcare Conference.
  • Regulation FD Disclosure: The Company is furnishing a corporate slide presentation (Exhibit 99.1) in connection with these meetings. This information is furnished, not filed, under Regulation FD and is not subject to Section 18 liabilities of the Exchange Act.
  • Management Signatory: The report was signed by Sherwin Sattarzadeh, Chief Operating Officer.

Investor Verification Checklist

  • Verify the content of the Corporate Presentation (Exhibit 99.1) attached to this filing for specific business updates, as the 8-K text itself contains no operational data.
  • Confirm the Company's ticker symbol is GLTO and not associated with Damora Therapeutics, Inc.
  • Note that the information provided is not "filed" for legal liability purposes under Section 18 of the Exchange Act.
  • Check subsequent filings for any financial results or material contracts that may have been discussed during the J.P. Morgan Healthcare Conference.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.